{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:34:19Z","timestamp":1770824059309,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4850,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/modpathol.2009.107","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T14:15:39Z","timestamp":1249049739000},"page":"1351-1360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location"],"prefix":"10.1016","volume":"22","author":[{"given":"Yu-Ching","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fong-Fu","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hock-Liew","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Huei","family":"Uen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Fang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shau-Hsuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.107_bib1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/cncr.21419","article-title":"Gastrointestinal stromal tumor: 5 years later","volume":"104","author":"van der Zwan","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2009.107_bib2","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"152","author":"Kindblom","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2009.107_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/hupa.2002.124124","article-title":"Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations","volume":"33","author":"Heinrich","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2009.107_bib4","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.107_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.1038\/modpathol.2009.107_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/hupa.2002.124123","article-title":"Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review","volume":"33","author":"Miettinen","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2009.107_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","article-title":"Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.107_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-200604000-00008","article-title":"Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.107_bib9","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.107_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2009.107_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2009.107_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2559.2008.02977.x","article-title":"Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours","volume":"53","author":"Lasota","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2009.107_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and merlin: integrators at the cell cortex","volume":"3","author":"Bretscher","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/modpathol.2009.107_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molmed.2004.03.001","article-title":"Ezrin, a key component in tumor metastasis","volume":"10","author":"Hunter","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1038\/modpathol.2009.107_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1040-8428(02)00172-5","article-title":"The role of the CD44\/ezrin complex in cancer metastasis","volume":"46","author":"Martin","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/modpathol.2009.107_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/emboj\/16.1.35","article-title":"Ezrin is a cyclic AMP-dependent protein kinase anchoring protein","volume":"16","author":"Dransfield","year":"1997","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.2009.107_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm966","article-title":"Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators","volume":"10","author":"Yu","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2009.107_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0304-3835(99)00272-4","article-title":"Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells","volume":"147","author":"Ohtani","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1038\/modpathol.2009.107_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nm982","article-title":"The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis","volume":"10","author":"Khanna","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2009.107_bib20","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0002-9440(10)64816-X","article-title":"Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas","volume":"157","author":"Geiger","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2009.107_bib21","first-page":"1171","article-title":"Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma","volume":"27","author":"Kim","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1038\/modpathol.2009.107_bib22","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.1158\/1078-0432.CCR-05-0548","article-title":"Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas","volume":"11","author":"Weng","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.107_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/gut.2003.021238","article-title":"Molecular targets for tumour progression in gastrointestinal stromal tumours","volume":"53","author":"Koon","year":"2004","journal-title":"Gut"},{"key":"10.1038\/modpathol.2009.107_bib24","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1038\/sj.onc.1208056","article-title":"Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles","volume":"23","author":"Subramanian","year":"2004","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.107_bib25","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1245\/s10434-006-9188-4","article-title":"Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria","volume":"13","author":"Huang","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/modpathol.2009.107_bib26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.surg.2007.01.024","article-title":"A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome","volume":"141","author":"Huang","year":"2007","journal-title":"Surgery"},{"key":"10.1038\/modpathol.2009.107_bib27","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1158\/1078-0432.CCR-08-1369","article-title":"Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors","volume":"14","author":"Li","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.107_bib28","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1200\/JCO.2005.19.554","article-title":"Deletions affecting codons 557\u2013558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)","volume":"23","author":"Martin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.107_bib29","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1053\/j.gastro.2006.01.043","article-title":"Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis","volume":"130","author":"Andersson","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2009.107_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/hupa.2002.123545","article-title":"Diagnosis of gastrointestinal stromal tumors: a consensus approach","volume":"33","author":"Fletcher","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2009.107_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cncr.23199","article-title":"Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)","volume":"112","author":"Dematteo","year":"2008","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2009.107_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jso.20230","article-title":"Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy","volume":"90","author":"Heinrich","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1038\/modpathol.2009.107_bib33","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2007.2002","article-title":"NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)\u2014update of the NCCN clinical practice guidelines","volume":"5","author":"Demetri","year":"2007","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/modpathol.2009.107_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0090-8258(03)00262-2","article-title":"Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients","volume":"90","author":"Moilanen","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2009.107_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAI.0b013e31818a6f5c","article-title":"The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression","volume":"17","author":"Ten Heuvel","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2009.107_bib36","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1158\/1078-0432.CCR-03-0715","article-title":"Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site","volume":"10","author":"Antonescu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.107_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/path.2402","article-title":"Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions","volume":"216","author":"Haller","year":"2008","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2009.107_bib38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nrc1213","article-title":"Merlin and ERM proteins: unappreciated roles in cancer development?","volume":"3","author":"McClatchey","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2009.107_bib39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/418823a","article-title":"A progression puzzle","volume":"418","author":"Bernards","year":"2002","journal-title":"Nature"},{"key":"10.1038\/modpathol.2009.107_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10585-006-9033-y","article-title":"Ezrin mediates growth and survival in Ewing's sarcoma through the AKT\/mTOR, but not the MAPK, signaling pathway","volume":"23","author":"Krishnan","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"10.1038\/modpathol.2009.107_bib41","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1158\/1078-0432.CCR-06-0456","article-title":"The signaling and biological implications of FAK overexpression in cancer","volume":"12","author":"Siesser","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.107_bib42","doi-asserted-by":"crossref","first-page":"37686","DOI":"10.1074\/jbc.M106175200","article-title":"Ezrin interacts with focal adhesion kinase and induces its activation independently of cell-matrix adhesion","volume":"276","author":"Poullet","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2009.107_bib43","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2007-09-110510","article-title":"Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia","volume":"111","author":"Monni","year":"2008","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009107","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:59:26Z","timestamp":1760230766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222024577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0893395222024577"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.107","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}